OTUB2 and neoplasm: To extend functional studies to other cancer types, we used CRISPR/Cas9 technology to genetically delete the OTUB2 gene in three mouse tumor cell lines (MC38, LL/2 and B16-F10) (Supplementary Fig. 6a−c).